The Venture Capital Podcast with Fexingo: VCs, Term Sheets, and Startup Investing

The Venture Capital Podcast with Fexingo: VCs, Term Sheets, and Startup Investing

By FexingoBusiness
Download on the App Store

The Venture Capital Podcast with Fexingo: VCs, Term Sheets, and Startup Investing episodes

  • The Pro Rata Clause VCs Use to Block New Investors

    In this episode of The Venture Capital Podcast, Lucas and Luna unpack the pro rata clause — a term sheet provision that lets existing investors maintain their ownership percentage in future funding rounds. They explore how top-tier VCs use pro rata to block new investors, drive up valuations, and secure their position in high-growth startups. Using real data from recent rounds and the current market context (ARKK up 6% in five days, Shopify flat despite strong earnings), they explain why founders should think twice before granting broad pro rata rights. The hosts also discuss the rise of secondary market workarounds and what the clause means for retail investors looking at late-stage deals. A must-listen for founders negotiating their first term sheet and anyone trying to understand VC power dynamics.

    #ProRata #TermSheet #VentureCapital #StartupInvesting #Founders #SeriesA #VCClauses #SecondaryMarket #Dilution #IPO #Business #Finance #Entrepreneurship #FundingRound #InvestorRelations #CapTable #FexingoBusiness #BusinessPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    9 min
  • Why VCs Are Using Rolling Funds to Stay Nimble

    In this episode of The Venture Capital Podcast, Lucas and Luna explore the rise of rolling funds—a relatively new structure that lets VCs raise capital continuously instead of in fixed vintage years. Drawing on AngelList data showing rolling fund AUM surpassing $15 billion in early 2026, they discuss how this model gives GPs more flexibility and allows LPs to drip-feed commitments. But there are trade-offs: fee drag, alignment questions, and whether rolling funds truly democratize venture or just concentrate power among top managers. The hosts also tie in recent market moves—ARKK up 6% and ARKG up 10% in the past five days—to examine how rolling funds might amplify flows into thematic strategies like genomics and fintech. A must-listen for anyone navigating the changing LP-GP relationship.

    #RollingFunds #VentureCapital #AngelList #LP #GP #FeeDrag #ARKK #ARKG #CathieWood #Fintech #Genomics #StartupInvesting #TermSheets #Business #Technology #FexingoBusiness #BusinessPodcast #VCPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    10 min
  • Why VCs Are Funding Synthetic Biology Startups

    In this episode of The Venture Capital Podcast with Fexingo, Lucas and Luna explore the mechanics behind a new wave of VC funding in synthetic biology. They anchor on the recent 10.1% weekly jump in ARKG, Cathie Wood's genomics ETF, and the $2.8 billion Series C raised by Ginkgo Bioworks. Lucas breaks down why top firms like Founders Fund and Andreessen Horowitz are placing big bets on syn-bio, comparing the current moment to the early days of cloud computing. Luna challenges whether the hype is sustainable, pointing to regulatory hurdles and the long timelines for product commercialization. Together, they drill into one specific deal: the $450 million round for a startup engineering yeast to produce sustainable jet fuel. Expect concrete numbers, a clear thesis, and one actionable takeaway for founders considering this space.

    #SyntheticBiology #VentureCapital #GinkgoBioworks #ARKG #FoundersFund #AndreessenHorowitz #Biotech #StartupInvesting #Genomics #SustainableAviationFuel #CathieWood #SeriesC #BusinessPodcast #FexingoBusiness #Technology #Bioengineering #DealFlow #DeepTech

    Keep every episode free: buymeacoffee.com/fexingo

    9 min
  • The Earnest Money VCs Are Asking For Before Series A

    Lucas and Luna examine a quiet but growing trend in early-stage venture capital: VCs asking founders for 'earnest money'—a small cash deposit paid by the startup at signing to secure a term sheet, typically refundable only if the investor walks. Lucas traces the practice to a handful of high-demand rounds in early 2026, citing data from a leaked side letter at a Bay Area AI startup. Luna challenges whether this signals a power shift toward investors or just a negotiating gimmick that weakens founder leverage. The hosts also discuss how deposit structures vary—some linked to legal fees, others tied to exclusivity clauses—and what markers founders should watch for. The episode draws on recent market moves: the ARK Genomic Revolution ETF up 10% in five days, suggesting speculative froth that may embolden VCs to demand concessions. Lucas closes with a forward-looking note on whether earnest money could become standard in overheated subsectors like biotech and enterprise AI.

    #VentureCapital #EarnestMoney #TermSheet #SeriesA #FounderLeverage #StartupFunding #Negotiation #SideLetter #Deposit #Exclusivity #AIBiotech #ARKG #Business #Technology #FexingoBusiness #BusinessPodcast #VCTactics #EarlyStage

    Keep every episode free: buymeacoffee.com/fexingo

    9 min
  • The VC Roll-Up Strategy That Turns Startups Into Platforms

    In this episode of The Venture Capital Podcast, Lucas and Luna unpack the roll-up strategy that VCs are quietly using to turn fragmented markets into platform companies. They focus on the case of Mythos, a robotics startup that just raised a $200 million Series C to acquire its way to dominance — a playbook borrowed from Vista Equity Partners and Thoma Bravo. The hosts discuss how this approach differs from traditional venture growth, why it's gaining traction in hardware and AI (where integration is harder than software), and what it means for founders who get an acquisition offer from a roll-up buyer. Lucas points to recent data: ARKK is up 6% in the last five days, signaling risk-on appetite for thematic M&A. Luna questions whether roll-ups actually create durable value or just financial engineering. The conversation lands on the tension between speed and culture — and why the best roll-up buyers don't just buy revenue, they buy teams.

    #VC #RollUp #Mythos #Robotics #MergersAndAcquisitions #PlatformCompanies #VentureCapital #PrivateEquity #ThomaBravo #VistaEquityPartners #AI #Hardware #SeriesC #Business #Technology #FexingoBusiness #BusinessPodcast #StartupStrategy

    Keep every episode free: buymeacoffee.com/fexingo

    8 min
  • How VCs Are Buying Their Own Founders Out

    Lucas and Luna dig into the quiet rise of continuation funds, where VCs sell portfolio companies to themselves rather than letting outside buyers in. On this episode of The Venture Capital Podcast, they trace the mechanics through a real 2025 deal: a $400 million health-tech rollup orchestrated by a top-tier firm. They explain why limited partners are getting squeezed, how the SEC is starting to pay attention, and what it means for founders who thought their VC was strictly on their side. Fresh data from June 2026 shows the S&P 500 up 6% this year while venture returns lag, making these internal deals more tempting than ever. If you've heard the term 'GP-led secondaries' but weren't sure how they actually work — or why they matter to anyone holding a startup stake — this episode gives you the blueprint.

    #ContinuationFunds #GPledSecondaries #VentureCapital #PrivateEquity #FounderEquity #LPSqueeze #SEC #PortfolioManagement #HealthTech #TermSheet #CapitalMarkets #StartupExit #Business #Finance #Investing #FexingoBusiness #BusinessPodcast #VCPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    10 min
  • The VC Reference Check That Actually Matters

    Lucas and Luna dig into a term sheet detail that founders often breeze past: the reference call. Not the informal chatter with other investors, but the structured diligence that can reveal whether a board member adds value or adds friction. Lucas shares a story about a late-stage startup that nearly took a term sheet from a top-tier firm, only to discover through three strategic reference calls that the partner had a pattern of overruling founders on hiring decisions. Luna counters with data from a 2025 survey showing that 40 percent of founders regret not doing deeper diligence on their lead investor. They talk about which references actually matter, how to structure the conversation, and why the partner's portfolio CFOs and operating partners are better sources than other founders. Tied to today's headlines about the Baseten fundraise and Elastic's acquisition of DeductiveAI, Lucas and Luna argue that in a market where mega-rounds are returning, the quality of governance capital matters more than ever.

    #VentureCapital #TermSheets #StartupInvesting #FounderDiligence #ReferenceCalls #BoardDynamics #GovernanceCapital #SeriesA #LateStage #Baseten #DeductiveAI #Elastic #InvestorBehavior #FounderAdvice #Business #Technology #FexingoBusiness #BusinessPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    10 min
  • The Series A Valuation Gap VCs Are Hiding

    In Episode 60 of The Venture Capital Podcast, Lucas and Luna explore an uncomfortable reality of early-stage investing in mid-2026: the widening gap between what founders think their Series A is worth and what VCs are actually paying. Using fresh data from the recent IPO filings of companies like Reddit and the performance of ARKK (up 4.6% in five days), they break down how down rounds are becoming the new normal, why the median Series A valuation has barely budged while late-stage valuations surged, and the clauses VCs insert to protect themselves when the next round comes at a lower number. Lucas walks through a specific case — a B2B SaaS startup that raised a $12 million Series A at a $45 million pre-money with a weighted-average anti-dilution provision — and explains exactly how that plays out if the Series B comes at $35 million. Luna challenges whether founders should just hold out for better terms, and Lucas argues that the window is shrinking. They close with the broader question: is venture capital becoming a buyer's market again?

    #SeriesA #VentureCapital #StartupValuations #DownRounds #AntiDilution #TermSheets #FounderAdvice #Business #Technology #Investing #RedditIPO #ARKK #LiquidationPreferences #CapTables #SeedStage #LateStage #FexingoBusiness #BusinessPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    10 min
  • Why Top VCs Are Betting on AR Glasses Despite Snap's Stumble

    Snap's stock tumbled 12% after unveiling $1,500 AR glasses that critics called a 'developer demo masquerading as a product.' But Lucas and Luna dig into why several top-tier venture firms are quietly doubling down on augmented reality hardware — and how a contrarian thesis from Chi-Hua Chien suggests the real AI winners won't be selling AI at all. They break down the numbers: Snap's AR hardware investment has consumed $2.8 billion since 2021, yet its core ad business still generates 98% of revenue. Meanwhile, ETFs tracking AR and genomics — ARKK and ARKG — have jumped 4% in the past week, signaling renewed appetite for moonshot tech. The episode explores why some VCs see Snap's stumble as a buying opportunity, not a warning sign, and what the AR playbook can teach founders about patience in a hype-driven market.

    #Snapchat #ARGoggles #VentureCapital #ChiHuaChien #AugmentedReality #ContrarianBet #StartupInvesting #TermSheets #GrowthEquity #MoonshotTech #ARKK #ARKG #AIWinners #HardwareStartups #Business #Technology #FexingoBusiness #BusinessPodcast

    Keep every episode free: buymeacoffee.com/fexingo

    9 min
  • The AI-Native Deal Flow VCs Are Quietly Building

    Episode 58 of The Venture Capital Podcast with Fexingo. Lucas and Luna dig into a structural shift in how VCs source deals: the rise of AI-native deal flow tools. They explore how firms like Sequoia and a16z are using internal large language models to scan startup databases, pitch decks, and social signals for patterns humans miss. Lucas cites new data from a 2026 survey by the National Venture Capital Association showing that 38% of early-stage firms now use proprietary AI for sourcing, up from 12% in 2024. Luna pushes back on whether this creates a filter bubble. They reference today's ARKK jump of 6.6% as a proxy for renewed risk appetite, and the Odyssey $1.45B round as a deal that likely passed through an AI filter. The episode asks: are VCs outsourcing serendipity, or just scaling pattern recognition?

    #VentureCapital #AIDealFlow #StartupInvesting #Sequoia #A16Z #NVCA #PatternRecognition #Odyssey #ARKK #TechStack #Business #Technology #Podcast #FexingoBusiness #BusinessPodcast #TermSheets #DealSourcing #AIFilter

    Keep every episode free: buymeacoffee.com/fexingo

    8 min

About The Venture Capital Podcast with Fexingo: VCs, Term Sheets, and Startup Investing

From the publisher's feed

Lucas and Luna sit across from each other at a Sand Hill Road conference table, a term sheet between them, dissecting the mechanics of venture capital. Each episode of The Venture Capital Podcast with Fexingo is a real-time examination of startup investing: the arithmetic of liquidation preferences, the nuance of anti-dilution clauses, the signal in a down round. They never opine for the sake of opinion. Instead, they pull live data — deal flow from PitchBook, valuation trends from Carta, IPO filings from the SEC — and ask the questions a thoughtful investor would ask: What does this cap table tell us about founder alignment? How do these LP terms shift the fund's risk profile? Is this market multiple justified by the unit economics? Lucas, with his journalist's precision, sets the scene: a round closes, a unicorn flatpacks, a new fund announces. Luna, the engaged interlocutor, challenges assumptions, pokes at the fine print, and connects the numbers to the people behind them. They name names — Accel, Sequoia, a16z — but never for hype; always for the lesson embedded in the deal. This show is for founders who've heard 'market standard' one too many times, VCs who want to sharpen their thesis, and anyone who believes that the best venture conversations are about structure, not spin. What happens when the term sheet you're handed isn't the one you thought you'd see?